Price caps on COVID-19 treatment in some states can dent margins for the industry Availability of funds due to recent measures announced by the Reserve Bank of India (RBI) can result in increased capacities and improve healthcare infrastructure in the long-term, investment information agency ICRA has said. On May 5, the RBI announced an on-tap liquidity window of Rs 50,000 crore with a tenor of up to three years that can be provided by banks for lending support to entities like hospitals, diagnostics, pharmacies, pharmaceutical companies or importers, medical oxygen manufacturers and suppliers and other operators involved in the critical healthcare supply chain.